Creative Planning’s TetraLogic Pharmaceuticals Corporation TLOG Stock Holding History

Creative Planning’s Portfolio TLOG Stock Details TLOG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-12,102	Closed	-$2K	–	5069
2016 Q3	$2K	Hold	12,102	–	–	﹤0.01%	4323
2016 Q2	$4K	Hold	12,102	–	–	﹤0.01%	3830
2016 Q1	$2K	Sell	12,102 -10,200	-46%	-$2.83K	﹤0.01%	4053
2015 Q4	$39K	Buy	22,302 +10,200	+84%	+$18K	﹤0.01%	2333
2015 Q3	$22K	Buy	+12,102	New	+$28.8K	﹤0.01%	2668

Other funds holding TLOG

California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return

BWA

Burt Wealth Advisors North Bethesda, Maryland $407M AUM 11.98% 1-Year Est. Return

Creative Planning's TLOG Position: Q4 2016 in Review

Creative Planning sold out of TetraLogic Pharmaceuticals Corporation (TLOG) in Q4 2016, closing a stake of 12,102 shares — an estimated $2K sold.

Creative Planning first reported a position in TLOG in Q3 2015 and held it in 5 quarters. The position peaked at $39K in Q4 2015. 3 funds tracked by Wall St. Rank hold TLOG as of Q4 2016.

Creative Planning reported no remaining TetraLogic Pharmaceuticals Corporation position as of Q4 2016 after selling out during the quarter.
Creative Planning sold 12,102 TetraLogic Pharmaceuticals Corporation shares in Q4 2016, an estimated $2K.
Creative Planning first reported a position in TetraLogic Pharmaceuticals Corporation in Q3 2015 and held it in 5 quarters.
Creative Planning's TetraLogic Pharmaceuticals Corporation position peaked at $39K in Q4 2015.
3 funds tracked by Wall St. Rank held TetraLogic Pharmaceuticals Corporation as of Q4 2016.

Based on Creative Planning's 13F filing for Q4 2016, filed 9 Jan 2017.